Literature DB >> 1698518

The effects of dihydropyridine calcium channel modulators on pentylenetetrazole convulsions.

S K O'Neill1, G T Bolger.   

Abstract

The effects of low doses of dihydropyridine (DHP) calcium channel antagonists nimodipine, nifedipine, (-)-R-202-791, and amlodipine, the DHP calcium channel agonist BAY K 8644 were investigated on clonic convulsions to pentylenetetrazole (PTZ) in mice. Nimodipine (2-20 mg/kg) produced a dose-dependent increase in the onset time for convulsions, but did not decrease the number of mice convulsing. Nifedipine, amlodipine (10 mg/kg) and BAY K 8644 (2 mg/kg) also produced an increase in the onset time for convulsions. (-)-R-202-791 (10 mg/kg) was without effect on clonic convulsions to PTZ. BAY K 8644 increased the number of mice dying from tonic-extension convulsions to PTZ. Nimodipine did not affect convulsions elicited by strychnine. Thus, low doses of DHP calcium antagonists possess anticonvulsant properties which are structurally dependent, while DHP calcium channel activators may act to promote convulsions. These observations suggest and support previous evidence that DHP receptors are important modulatory sites for the convulsive state.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698518     DOI: 10.1016/0361-9230(90)90279-9

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  3 in total

1.  Design, Synthesis and Anti-Tubercular Activity of Novel 1, 4-Dihydropyrine-3, 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety.

Authors:  Maryam Iman; Asghar Davood; Mahboubeh Lotfinia; Golnoush Dehqani; Soroush Sardari; Parisa Azerang; Mohsen Amini
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

2.  Anti-Convulsant Activity of Boerhaavia diffusa: Plausible Role of Calcium Channel Antagonism.

Authors:  Mandeep Kaur; Rajesh Kumar Goel
Journal:  Evid Based Complement Alternat Med       Date:  2011-01-09       Impact factor: 2.629

3.  Design, Synthesis and Evaluation of Antitubercular Activity of Novel Dihydropyridine Containing Imidazolyl Substituent.

Authors:  Maryam Iman; Asghar Davood; Golnoush Dehqani; Mahboubeh Lotfinia; Soroush Sardari; Parisa Azerang; Mohsen Amini
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.